Is adrenomedullin a causal agent in some cases of type 2 diabetes?

Peptides

Volumn 20, Issue 12, 1999, Pages 1471-1478

  Martinez A ^a   Elsasser, T H ^b   Bhathena, S J ^b   Pio R ^a   Buchanan, T A ^c   Macri, C J ^d   Cuttitta, F ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Adrenomedullin; Diabetic rat model; Gestational diabetes; Glucose tolerance; Glycemia regulation; Radioimmunoassay

Indexed keywords

ADRENOMEDULLIN; GLUCOSE; INSULIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS FUNCTION; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

ADOLESCENT; ADRENOMEDULLIN; ADULT; ANIMALS; ANTIBODIES; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES; PHENOTYPE; PREDIABETIC STATE; PREGNANCY; RATS; RATS, INBRED SHR;

EID: 0242452956     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(99)00158-8     Document Type: Article

References (49)

1. Aiyar N., Disa J., Feuerstein G.Z., Porter T.P., Siemens I.R. Adrenomedullin receptor characterization using the selective antagonist adrenomedullin (22-52) (abst). FASEB J. 10:1996;A686.
2. Allen M.A., Ferguson A.V. In vitro recordings from area postrema neurons demonstrate responsiveness to adrenomedullin. Am J Physiol. 270:1996;R920-R925.
3. Briner V.A., Lüscher T.F. Role of vascular endothelial abnormalities in clinical medicine atherosclerosis, hypertension, diabetes, and endotoxemia . Adv Intern Med. 39:1994;1-22.
4. Brownlee M., Cerami A., Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 318:1988;1315-1321.
5. Brunicardi F.C., Shavelle D.M., Andersen D.K. Neural regulation of the endocrine pancreas. Int J Pancreatol. 18:1995;177-195.
6. Buchanan T.A., Metzger B.E., Freinkel N., Bergman R.N. Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol. 162:1990;1008-1014.
7. Cerasi E., Nesher R., Gadot M., Gross D., Kaiser N. Insulin secretion in obese and non-obese NIDDM. Diabetes Res Clin Pract. 28:(suppl.):1995;S27-S37.
8. Champion H.C., Friedman D.E., Lambert D.G., Murphy W.A., Coy D.H., Kadowitz P.J. Adrenomedullin (16-31) has pressor activity in the rat but not in the cat. Peptides. 18:1997;133-136.
9. Cheung B., Leung R. Elevated plasma levels of human adrenomedullin in cardiovascular, respiratory, hepatic, and renal disorders. Clin Sci. 92:1997;59-62.
10. Di Ioro R., Marinoni E., Scavo D., Letizia C., Cosmi E.V. Adrenomedullin in pregnancy. Lancet. 349:1997;328.
11. García-Unzueta M.T., Montalbán C., Pesquera C., Berrazueta J.R., Amado J.A. Plasma adrenomedullin levels in type 1 diabetes. Diabetes Care. 21:1998;999-1003.
12. Greenhouse D.D., Michaelis O.E., McCune S.A. Development of corpulent rat strains. Shafrir D. Frontiers in diabetes research lessons from animal diabetes . 1990;375-377 Smith-Gordon and Co. Ltd, London.
13. Gumusel B., Chang J.K., Hyman A., Lippton H. Adrenotensin an ADM gene product with the opposite effects of ADM . Life Sci. 57:1995;87-90.
14. Hayashi M., Shimosawa T., Fujita T. Hyperglycemia increases vascular adrenomedullin expression. Biochem Biophys Res Commun. 258:1999;453-456.
15. Hayashi M., Shimosawa T., Isaka M., Yamada S., Fujita R., Fujita T. Plasma adrenomedullin in diabetes. Lancet. 350:1997;1449-1450.
16. Hirata Y., Mitaka C., Sato K., Nagura T., Tsunoda Y., Amaha K., Marumo F. Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. J Clin Endocrinol Metab. 81:1996;1449-1453.
17. Ishimitsu T., Nishikimi T., Saito Y. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypotension and renal failure. J Clin Invest. 94:1994;2158-2161.
18. Jougasaki M., Wei C.M., Aarhus L.L., Heublen D.M., Sandberg S.M., Burnett J.C. Renal localization and actions of adrenomedullin; a natriuretic peptide. Am J Physiol. 268:1995;657-663.
19. Kapas S., Catt K.J., Clark J.L. Cloning and expression of cDNA encoding a rat adrenomedullin receptor. J Biol Chem. 270:1995;24344-24347.
20. Kapas S., Martínez A., Cuttitta F., Hinson J.P. Local production and action of adrenomedullin in the rat adrenal zona glomerulosa. J Endocrinol. 156:1998;477-484.
21. Kato F., Kitamura K., Niina H., Yamamoto R., Washimine H., Kangawa K., Yamamoto Y., Kobayashi H., Eto T., Wada A. Proadrenomedullin N-terminal 20 peptide (PAMP), an endogenous anticholinergic peptide its exocytotic secretion and inhibition of catecholamine secretion in adrenal medulla . J Neurochem. 64:1995;459-461.
22. Kjos S.L., Peters R.K., Xiang A., Henry O.A., Montoro M.N., Buchanan T.A. Predicting future diabetes in Latino women with gestational diabetes utility of early postpartum glucose tolerance testing . Diabetes. 44:1995;586-591.
23. Kobayashi K, Kubota T, Hirata Y, Marumo F, Aso T. Study on immunoreactive adrenomedullin in maternal plasma during human pregnancy. 10th International Congress of Endocrinology 846 (Abstract); 1996.
24. Livesey J.H., Donald R.A. Prevention of adsorption losses during radioimmunoassay of polypeptide hormones effectiveness of albumins, gelatin, caseins, Tween 20 and plasma . Clin Chem Acta. 123:1982;193-198.
25. Macri C.J., Martínez A., Moody T.W., Gray K.D., Miller M.J., Gallagher M., Cuttitta F. Detection of adrenomedullin, a hypotensive peptide, in amniotic fluid and fetal membranes. Am J Obstet Gynecol. 175:1996;906-911.
26. Malaisse WJ. The beta cell in NIDDM: giving light to the blind. Diabetologia 37, Suppl.1994;2:S36-42.
27. Martínez A., Cuttitta F. Adrenomedullin. 1998;IOS Press, Amsterdam.
28. Martínez A., Cuttitta F., Teitelman G. Expression pattern for adrenomedullin during pancreatic development in the rat reveals a common precursor with other endocrine cell types. Cell Tissue Res. 293:1998;95-100.
29. Martínez A., Elsasser T., Muro-Cacho C., Moody T.W., Miller M.J., Macri C.J., Cuttitta F. Expression of adrenomedullin and its receptor in normal and malignant human skin a potential pluripotent role in the integument . Endocrinology. 138:1997;5597-5604.
30. Martínez A., Weaver C., López J., Bhathena S.J., Elsasser T.H., Miller M.J., Moody T.W., Unsworth E.J., Cuttitta F. Regulation of insulin secretion and blood glucose metabolism by adrenomedullin. Endocrinology. 137:1996;2626-2632.
31. Martínez V., Cuttitta F., Taché Y. Central action of adrenomedullin to inhibit gastric emptying in rats. Endocrinology. 138:1997;3749-3755.
32. McDermott A.M., Sharp G.W. Inhibition of insulin secretion a fail-safe system . Cell Signal. 5:1993;229-234.
33. Metzger B.E., Cho N.H., Roston S.M., Rodvany R. Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care. 16:1993;1598-1605.
34. Miller M.J., Martínez A., Unsworth E.J., Thiele C.J., Moody T.W., Cuttitta F. Adrenomedullin expression in human tumor cell lines its potential role as an autocrine growth factor . J Biol Chem. 271:1996;23345-23351.
35. Montuenga L.M., Martínez A., Miller M.J., Unsworth E.J., Cuttitta F. Expression of adrenomedullin and its receptor during embryogenesis suggests autocrine or paracrine modes of action. Endocrinology. 138:1997;440-451.
36. Mulshine J.L., Linnoila R.I., Magnani J.L. Applications of monoclonal antibodies in the management of lung cancer patients. Pass H.I. Chest surgery clinics of North America adjunctive and alternative treatment of bronchogenic lung cancer . 1991;153-189 WB Saunders Co, Philadelphia.
37. Nakamura T., Honda K., Ishikawa S., Kitamura K., Eto T., Saito T. Plasma adrenomedullin levels in patients with non-insulin dependent diabetes mellitus close relationships with diabetic complications . Endocrine J. 45:1998;241-246.
38. National Institute of Diabetes, and Digestive, and Kidney Diseases. Diabetes in America, 2nd Edition. Washington, DC: NIH Publication No. 95-1468, 1995.
39. Nuki C., Kawasaki H., Kitamura K., Takenaga M., Kangawa K., Eto T., Wada A. Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesenteric vascular beds. Biochem Biophys Res Commun. 196:1993;245-251.
40. O'Sullivan J.B. Diabetes after GDM. Diabetes. 40:(suppl. 2):1991;131-135.
41. Samson W.K., Murphy T., Schell D.A. A novel vasoactive peptide, adrenomedullin, inhibits pituitary adrenocorticotropin release. Endocrinology. 136:1995;2349-2352.
42. SAS Institute. SAS procedures guide for personal computers, Version 6 edition. Cary, NC: SAS, 1985.
43. Sato A., Canny B.J., Autelitano D.J. Adrenomedullin stimulates cAMP accumulation and inhibits atrial natriuretic peptide gene expression in cardiomyocytes. Biochem Biophys Res Commun. 230:1997;311-314.
44. 2+ mobilization, in bovine aortic endothelial cells. J Biol Chem. 270:1995;4412-4417.
45. Walsh TJ, Martínez A, Peter MJ, Miller MJ, Unsworth E, Cuttitta F. Antimicrobial activity of adrenomedullin and its gene-related peptides. The Infectious Diseases Society of America (IDSA) Annual Meeting (Abstract) Chicago, IL: University of Chicago Press, 1996.
46. Ward W.K., Johnston C.L.W., Beard J.C., Benedetti T.J., Halter J.B., Porte D. Insulin resistance and impaired insulin secretion in subjects with a history of gestational diabetes mellitus. Diabetes. 34:1985;861-869.
47. Whiters D.J., Coppock H.A., Seufferlein T., Smith D.M., Bloom S.R., Rozengurt E. Adrenomedullin stimulates DNA synthesis and cell proliferation via elevation of cAMP in Swiss 3T3 cells. FEBS Lett. 378:1996;83-87.
48. Wu J.T. Review of diabetes identification of markers for early detection, glycemic control, and monitoring clinical complications . J Clin Lab Anal. 7:1993;293-300.
49. Yamaguchi T., Baba K., Doi Y., Yano K. Effect of adrenomedullin on aldosterone secretion by dispersed rat adrenal zona glomerulosa cells. Life Sci. 56:1995;379-387.